• Users Online: 642
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 53  |  Issue : 1  |  Page : 31-37

Treatment of knee osteoarthritis with platelet-rich plasma in comparison with platelet-rich plasma plus hyaluronic acid: a short-term double-blind randomized clinical study

Department of Orthopedic, School of Medicine, Helwan University, Cairo, Egypt

Correspondence Address:
El-Tayeb Nasser
Orthopedics Faculty of Medicine Ain Shams University, Building Number 40 Taawniat, Masakin Shiraton, Nozha, Cairo, 11799
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/eoj.eoj_13_18

Rights and Permissions

Background Platelet-rich plasma (PRP) and hyaluronic acid (HA) intra-articular knee injections are widely accepted as modalities to treat pain and functional limitation associated with knee osteoarthritis. So it can be assumed that a combination of both HA and PRP in one injection could supply many advantages for cartilage repair. It adds the benefit of HA viscosupplementation with PRP regenerative properties. This study aims at finding out whether blending HA with PRP gives better clinical and functional results when compared with PRP intra-articular injection alone. Patients and methods A prospective, double-blind, randomized, multicenter clinical trial was conducted. It included 58 patients with average age of 35 years (range: 29–49 years), started on January 2016 and ended on June 2017. Each patient had initial assessment, and then were followed up after 6 months and then at 12 months. They were randomized into two groups: group 1 (PRP) (24 cases) was injected with PRP only and group 2 (PRP+HA) (34 cases) was injected with PRP plus highly cross-linked sodium hyaluronate. Results Initially, both groups were matched in age and BMI, with P value more than 0.05. Both groups were also matched on their initial assessment by the three clinical assessment methods, namely, knee society score, global impression of changes, and the Western Ontario and McMaster Universities Arthritis Index, with P value more than 0.05. Comparing groups 1 and 2 regarding the follow-up results showed, globally, no significant superiority of group 2 (PRP+HA) over group 1 (PRP). It was quite apparent in global impression of changes at 6 and 12 months, and in Western Ontario and McMaster Universities Arthritis Index at 6 and 12 months, with P value more than 0.05. Knee society score gives results with group 1 (PRP group) at 6 month and after 1 year follow-up, which were better than the results of group 2 (PRP+HA), with P value less than 0.05. Follow-up of each group of patient separately at 6 months and 1 year showed that each of them has highly significant improvement regarding pain and functional outcome, with P value less than 0.001. Conclusion PRP intra-articular injection appears to improve pain and function in middle-aged women with mild to moderate knee osteoarthritis, with no added benefit of blending HA with PRP during injection.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded67    
    Comments [Add]    

Recommend this journal